

AbCellera Biologics is planning to break ground in late 2021 on a manufacturing plant for therapeutic antibodies in Vancouver, British Columbia. Supported by $175.6 million in federal funding, the 130,000-sf project will cost approximately CAD$240 million to build. Offering advanced production suites, labs, offices, and warehouse space, the GMP facility will enhance the country's ability to create vaccines in response to future pandemic threats.
The International Microbiome Centre (IMC) at the University of Calgary houses one of the largest germ-free facilities in the world and the only one that has incorporated intra-vital imaging. Constructed in a portion of the basement at the Cumming School of Medicine, the germ-free facility complements the other microbiome platforms—including mass cytometry, genomics, proteomics, metabolomics, bioinformatics, biobanking, and live cell imaging—by providing a model system in which to study the microbiome. The center provides a sterilized housing environment, where researchers explore the microbiome and its impact through adding bacteria to germ-free models and analyzing what those bacteria do to the animals’ immune systems, organs, and overall health.